Sample pooling, a population screening strategy for SARS-CoV2 to prevent future outbreak and mitigate the second-wave of infection of the virus
Sawarkar, S. S.; Victor, A.; Viotti, M.; Haran, S. P.; Verma, S.; Griffin, D.; Sams, J.
Show abstract
ProblemHow do we manage treatment and stabilization in clinical settings and static population communities like assisted living facility settings of their patient or resident populations during and post the SARS-CoV-2 pandemic? ScopeThis proposal explores the possible and predicted changes to standard operating procedures to the facility management and associated landscape and focuses on series of deployments, during and post peak SARS-CoV-2 activity, and will outline possible models for the current medical facility model that we operate with. This article primarily focuses on non-emergency facility management. Assumptions and understanding of the fieldWith a reduction in the numbers nationally, patients are highly motivated and likely to seek non-emergency and planned medical procedural treatment as early as possible as social distancing measures are eased and restrictions on non-urgent procedures are lifted. Conclusions and next stepsAn initial pan-national shutdown and suspension of services was necessary in an effort to ensure that essential medical services and resources were not strained. The authors feel that a strategic resumption of regular non-emergency treatments around the United States and continued provision of services at care facilities is possible with innovative testing strategies like pooled screening of large populations at a manageable price point. Moreover, pooling as a strategy when used widely, would be extremely effective at predicting outbreaks of the virus and as an effect help in mitigating the spread of the virus in its "second-wave". We have developed one such innovative pooling strategy that can be easily deployed across laboratories and reduce the cost of population wide COVID-19 testing significantly
Matching journals
The top 9 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Sample pooling methods for efficient pathogen screening: Practical implications 95%
- SARS-CoV-2 detection in multi-sample pools in a real pandemic scenario: a screening strategy of choice for active surveillance 94%
- Performance of the TaqMan™ COVID-19 Pooling Kit for detection of SARS-CoV-2 in Asymptomatic and Symptomatic populations at an Institution of Higher Education 94%
Similar papers in this journal
- Evidence-based pandemic preparedness: an infrastructure for population-scale genome-based based testing for COVID-19 93%
- Design of Specific Primer Set for Detection of B.1.1.7 SARS-CoV-2 Variant using Deep Learning 93%
- Distinct SARS-CoV-2 Antibody Reactivity Patterns in Coronavirus Convalescent Plasma Revealed by a Coronavirus Antigen Microarray 93%
Similar papers in this journal
- Bigger and Better? Representativeness of the Influenza A surveillance using one consolidated clinical microbiology laboratory data set as compared to the Belgian Sentinel Network of Laboratories 93%
- Providing a safe, in-person, residential college experience during the COVID-19 pandemic 92%
- Accuracy of US CDC COVID-19 Forecasting Models 92%
Similar papers in this journal
- Performance of a point of care test for detecting IgM and IgG antibodies against SARS-CoV-2 and seroprevalence in blood donors and health care workers in Panama 94%
- SARS-CoV-2 testing in the Slovak Republic from March 2020 to September 2022 – summary of the pandemic trends 93%
- False Negative Mitigation in Group Testing for COVID-19 Screening 92%
Similar papers in this journal
- Self-collected oral, nasal and saliva samples yield sensitivity comparable to professional-collected oro-nasopharyngeal swabs in SARS-CoV-2 diagnosis 93%
- Performance evaluation of novel fluorescent-based lateral immune flow assay (LIFA) for rapid detection and quantitation of total anti-SARS-CoV-2 S-RBD binding antibodies in infected individuals 92%
- Assessment of Commercial SARS-CoV-2 Antibody Assays, Jamaica 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.